Detalhe da pesquisa
1.
The somatic genomic landscape of glioblastoma.
Cell
; 155(2): 462-77, 2013 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-24120142
2.
ABTC-0904: targeting glioma stem cells in GBM: a phase 0/II study of hedgehog pathway inhibitor GDC-0449.
J Neurooncol
; 161(1): 33-43, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36581779
3.
BRCA1 Protein Expression Predicts Survival in Glioblastoma Patients from an NRG Oncology RTOG Cohort.
Oncology
; 99(9): 580-588, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33957633
4.
A single institution retrospective analysis on survival based on treatment paradigms for patients with anaplastic oligodendroglioma.
J Neurooncol
; 153(3): 447-454, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34125374
5.
Response assessment in paediatric high-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.
Lancet Oncol
; 21(6): e317-e329, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32502458
6.
A pilot precision medicine trial for children with diffuse intrinsic pontine glioma-PNOC003: A report from the Pacific Pediatric Neuro-Oncology Consortium.
Int J Cancer
; 145(7): 1889-1901, 2019 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30861105
7.
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors.
N Engl J Med
; 372(26): 2499-508, 2015 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-26061753
8.
Phase-2 trial of palbociclib in adult patients with recurrent RB1-positive glioblastoma.
J Neurooncol
; 140(2): 477-483, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30151703
9.
Phase I study of sorafenib and tipifarnib for recurrent glioblastoma: NABTC 05-02.
J Neurooncol
; 136(1): 79-86, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28988377
10.
Probing the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway in gliomas: A phase 2 study of everolimus for recurrent adult low-grade gliomas.
Cancer
; 123(23): 4631-4639, 2017 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28759109
11.
Combined BRAFV600E and MEK blockade for BRAFV600E-mutant gliomas.
J Neurooncol
; 131(3): 495-505, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27848137
12.
Precision knockdown of EGFR gene expression using radio frequency electromagnetic energy.
J Neurooncol
; 133(2): 257-264, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28434113
13.
Phase I trial of aflibercept (VEGF trap) with radiation therapy and concomitant and adjuvant temozolomide in patients with high-grade gliomas.
J Neurooncol
; 132(1): 181-188, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28116649
14.
Serial analysis of 3D H-1 MRSI for patients with newly diagnosed GBM treated with combination therapy that includes bevacizumab.
J Neurooncol
; 130(1): 171-179, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27535746
15.
Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant glioma.
J Neurooncol
; 126(3): 385-93, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26384810
16.
Clinical outcome and prognostic factors for central neurocytoma: twenty year institutional experience.
J Neurooncol
; 126(1): 193-200, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26493740
17.
Familial gliomas: cases in two pairs of brothers.
J Neurooncol
; 121(1): 135-40, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25208478
18.
Comparison of ADC metrics and their association with outcome for patients with newly diagnosed glioblastoma being treated with radiation therapy, temozolomide, erlotinib and bevacizumab.
J Neurooncol
; 121(2): 331-9, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25351579
19.
Use of External Control Cohorts in Pediatric Brain Tumor Clinical Trials.
J Clin Oncol
; 42(12): 1340-1343, 2024 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38394473
20.
Comparison of Volumetric and 2D Measurements and Longitudinal Trajectories in the Response Assessment of BRAF V600E-Mutant Pediatric Gliomas in the Pacific Pediatric Neuro-Oncology Consortium Clinical Trial.
AJNR Am J Neuroradiol
; 45(4): 475-482, 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38453411